AMZN vs ARTV · P/E 31, rev $716.92B vs $37.3M cap
Amazon.com Inc (AMZN) versus Artiva Biotherapeutics, Inc. Common Stock (ARTV) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. ARTV currently screens at market cap $37.3M.
Not investment advice. Open the AMZN and ARTV stock pages for the full models.
Not investment advice.